Last reviewed · How we verify
Placebo (for Omeprazole)
Placebo is a dummy treatment with no active pharmacological effect.
Placebo is a dummy treatment with no active pharmacological effect. Used for Symptomatic gastroesophageal reflux disease (GERD).
At a glance
| Generic name | Placebo (for Omeprazole) |
|---|---|
| Sponsor | Population Health Research Institute |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not interact with any biological molecules or systems. It is used as a control in clinical trials to compare the efficacy of active treatments.
Approved indications
- Symptomatic gastroesophageal reflux disease (GERD)
Common side effects
Key clinical trials
- Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM) (PHASE1)
- KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism (NA)
- Effects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal (NA)
- Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism (PHASE3)
- A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis (NA)
- Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans (PHASE3)
- The Mechanism Versus PPI Trial (PHASE4)
- A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for Omeprazole) CI brief — competitive landscape report
- Placebo (for Omeprazole) updates RSS · CI watch RSS
- Population Health Research Institute portfolio CI